Compare SER & GLBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SER | GLBS |
|---|---|---|
| Founded | 2017 | 2006 |
| Country | United States | Greece |
| Employees | 16 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.0M | 43.8M |
| IPO Year | 2024 | 2010 |
| Metric | SER | GLBS |
|---|---|---|
| Price | $2.81 | $3.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $15.00 | $3.00 |
| AVG Volume (30 Days) | 40.9K | ★ 154.8K |
| Earning Date | 05-14-2026 | 06-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $130,000.00 | N/A |
| Revenue This Year | N/A | $13.06 |
| Revenue Next Year | N/A | $20.20 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 132.14 | N/A |
| 52 Week Low | $1.22 | $1.00 |
| 52 Week High | $7.92 | $3.85 |
| Indicator | SER | GLBS |
|---|---|---|
| Relative Strength Index (RSI) | 74.64 | 63.91 |
| Support Level | $1.74 | $1.43 |
| Resistance Level | $2.99 | N/A |
| Average True Range (ATR) | 0.16 | 0.28 |
| MACD | 0.07 | 0.06 |
| Stochastic Oscillator | 90.91 | 77.78 |
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.
Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.